Castle Biosciences Inc (CSTL)
29.81
+0.93
(+3.22%)
USD |
NASDAQ |
Nov 22, 16:00
29.81
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Total Liabilities (Quarterly): 73.51M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 73.51M |
| June 30, 2024 | 63.42M |
| March 31, 2024 | 56.04M |
| December 31, 2023 | 62.07M |
| September 30, 2023 | 50.24M |
| June 30, 2023 | 46.63M |
| March 31, 2023 | 41.74M |
| December 31, 2022 | 48.18M |
| September 30, 2022 | 46.38M |
| June 30, 2022 | 36.72M |
| March 31, 2022 | 47.09M |
| December 31, 2021 | 50.83M |
| Date | Value |
|---|---|
| September 30, 2021 | 21.98M |
| June 30, 2021 | 19.62M |
| March 31, 2021 | 18.74M |
| December 31, 2020 | 23.64M |
| September 30, 2020 | 43.84M |
| June 30, 2020 | 43.92M |
| March 31, 2020 | 32.32M |
| December 31, 2019 | 34.63M |
| September 30, 2019 | 30.86M |
| June 30, 2019 | 36.94M |
| March 31, 2019 | 28.96M |
| December 31, 2018 | 32.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.74M
Minimum
Mar 2021
73.51M
Maximum
Sep 2024
43.08M
Average
45.15M
Median
Total Liabilities (Quarterly) Benchmarks
| Delcath Systems Inc | 23.11M |
| Star Equity Holdings Inc | 27.35M |
| Exact Sciences Corp | 3.538B |
| CytoSorbents Corp | 34.80M |
| Progyny Inc | 225.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 514.56M |
| Shareholders Equity (Quarterly) | 441.06M |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 7.784 |
| Net Debt Paydown Yield | -0.25% |